KALA (KALA) Stock Price & Analysis
KALA (KALA) fell 9.57% to USD 0.51 as of September 8, 2026 at 06:55 UTC, according to Nexqual real-time market data.
KALA last closed at USD 0.51; the session ranged USD 0.5–0.56 on volume of 250,767 shares. Market capitalization is —, with a 52-week range of USD 0.5–1,030 (NCM). Source: Nexqual, September 8, 2026 at 06:55 UTC.
Key Statistics (as of September 8, 2026 at 06:55 UTC)
| Price | USD 0.51 |
|---|---|
| Change | ▼ 9.57% (down) |
| Previous Close | USD 0.51 |
| Open | USD 0.51 |
| Day Range | USD 0.5 – 0.56 |
| 52-Week Range | USD 0.5 – 1,030 |
| Volume | 250,767 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (KALA)
Nexqual's technical model rates KALA "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:55 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.18 (oversold) |
| vs SMA50 | Below (USD 0.95) |
| MACD | -0.13 (negative) |
Analyst Ratings (KALA)
Wall Street analysts rate KALA "None", per Nexqual as of September 8, 2026 at 06:55 UTC.
| Consensus Rating | None |
|---|
Earnings (KALA)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-09-30 | USD -53.5 vs est -50.5 ▼ miss |
| 2025-06-30 | USD -65.94 vs est -102 ▲ beat |
| 2025-03-31 | USD -50.66 vs est -127 ▲ beat |
| 2024-12-31 | USD -61.58 vs est -123.5 ▲ beat |
Source: Nexqual, September 8, 2026 at 06:55 UTC.
Financials & Fundamentals (KALA)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -345.32% |
| Current Ratio | 6.88 |
| Total Cash | $7.23M |
| Total Debt | $0 |
| Free Cash Flow | $-18.42M |
Source: Nexqual, September 8, 2026 at 06:55 UTC.
Ownership (KALA)
| Insider Ownership | +1.24% |
|---|---|
| Institutional Ownership | +3.61% |
| Shares Outstanding | 19.34M |
| Float | 19.34M |
| Short % of Float | +1.33% |
Source: Nexqual, September 8, 2026 at 06:55 UTC.
From KALA's Latest SEC 10-K Filing (filed 2026-04-15)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
| PALI | Palisade Bio, Inc. | USD 2.09 | ▲ 5.03% |
| NERV | Minerva Neurosciences, Inc | USD 4.43 | ▼ 1.12% |
| KPTI | Karyopharm Therapeutics Inc. | USD 1.79 | ▲ 0% |
| ARDX | Ardelyx, Inc. | USD 3.78 | ▼ 0.53% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:55 UTC. This page is informational and not investment advice.